ES2130426T3 - Vacuna que contiene una serina-proteasa. - Google Patents

Vacuna que contiene una serina-proteasa.

Info

Publication number
ES2130426T3
ES2130426T3 ES94917738T ES94917738T ES2130426T3 ES 2130426 T3 ES2130426 T3 ES 2130426T3 ES 94917738 T ES94917738 T ES 94917738T ES 94917738 T ES94917738 T ES 94917738T ES 2130426 T3 ES2130426 T3 ES 2130426T3
Authority
ES
Spain
Prior art keywords
protease
serine
vaccine containing
fight
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94917738T
Other languages
English (en)
Inventor
John Pius Dalton
Stuart John Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2130426T3 publication Critical patent/ES2130426T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE PROTEASAS DE SERINA CON UNA ACTIVIDAD PEPTIDASA DIPEPTIDIL EN LA FORMULACION DE VACUNAS PARA COMBATIR LOS PARASITOS DE HELMINTO, PREFERIBLEMENTE LA PROTEASA SE DERIVA DE UNA LOMBRIZ TAL COMO LA FASCIOLA HEPATICA.
ES94917738T 1993-06-15 1994-06-14 Vacuna que contiene una serina-proteasa. Expired - Lifetime ES2130426T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939312324A GB9312324D0 (en) 1993-06-15 1993-06-15 Vaccine

Publications (1)

Publication Number Publication Date
ES2130426T3 true ES2130426T3 (es) 1999-07-01

Family

ID=10737190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94917738T Expired - Lifetime ES2130426T3 (es) 1993-06-15 1994-06-14 Vacuna que contiene una serina-proteasa.

Country Status (14)

Country Link
US (1) US5885814A (es)
EP (1) EP0703789B1 (es)
JP (1) JPH08511262A (es)
AT (1) ATE176402T1 (es)
AU (1) AU694121B2 (es)
DE (1) DE69416405T2 (es)
DK (1) DK0703789T3 (es)
ES (1) ES2130426T3 (es)
GB (1) GB9312324D0 (es)
GR (1) GR3030116T3 (es)
HU (1) HUT71209A (es)
NZ (1) NZ267139A (es)
WO (1) WO1994028925A1 (es)
ZA (1) ZA944241B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
AUPO767497A0 (en) * 1997-07-04 1997-07-24 Australian Wool Research & Promotion Organisation Parasite vaccine
US20030065382A1 (en) * 2001-10-02 2003-04-03 Fischell Robert E. Means and method for the treatment of coronary artery obstructions
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
EP2017620A3 (en) 2004-04-28 2009-04-22 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (DPP1)
MX2012004133A (es) 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
MY200300A (en) * 2016-04-21 2023-12-19 4TEEN4 Pharmaceuticals GmbH Methods for determining dpp3 and therapeutic methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001277A1 (en) * 1986-08-18 1988-02-25 The Australian National University Helminth parasite vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
NZ230773A (en) * 1988-09-26 1993-04-28 Biotech Australia Pty Ltd Nematode antigenic peptides and vaccines
US6623735B1 (en) * 1992-10-21 2003-09-23 John P. Dalton Vaccine containing a thiol protease

Also Published As

Publication number Publication date
AU6933394A (en) 1995-01-03
ZA944241B (en) 1995-05-26
GB9312324D0 (en) 1993-07-28
WO1994028925A1 (en) 1994-12-22
JPH08511262A (ja) 1996-11-26
HUT71209A (en) 1995-11-28
DK0703789T3 (da) 1999-09-20
EP0703789B1 (en) 1999-02-03
HU9403591D0 (en) 1995-03-28
DE69416405D1 (de) 1999-03-18
DE69416405T2 (de) 1999-09-09
GR3030116T3 (en) 1999-07-30
ATE176402T1 (de) 1999-02-15
US5885814A (en) 1999-03-23
NZ267139A (en) 1998-01-26
EP0703789A1 (en) 1996-04-03
AU694121B2 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
DK0656888T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer
ES2155069T3 (es) Inhibidores de proteasas retrovirales.
AR017601A1 (es) TRATAMIENTO DE LENTES DE CONTACTO CON SOLUCIoN ACUOSA QUE COMPRENDE UN DESINFECTANTE BIGUANIDA Y UN SISTEMA TAMPoN FOSFATO Y BORATO COMPLEMENTARIO
ES2104946T3 (es) Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2192708T3 (es) Combinaciones de productos activos fungicidas.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
GT200000111A (es) Procedimiento para la obtencion de preparados farmaceuticos solidos de disgregacion rapida.
ES2185655T3 (es) Fracciones de acido aurintricarboxilico y analogos con actividad anti-angiogenica y metodos de uso.
DE69737500D1 (de) Von willebrand-faktor multimerase
ATE240397T1 (de) Thiolprotease enthaltender impfstoff
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2099164T3 (es) Vacuna de glicoproteina de ehv-4.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
ATE176402T1 (de) Serinprotease enthaltender impfstoff
DE69737691D1 (de) Impfstoff, der peroxiredoxin enthält
ES2133328T3 (es) Enzimas de detergente de verticillium.
ES2129563T3 (es) Empleo de una combinacion de un inhibidor de la enzima convertidora de angiotensina y un antagonista del calcio para el tratamiento de una proteinuria.
ES2073174T3 (es) Nuevas proteasas.
ES2060076T3 (es) Nuevos derivados de tetralina.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
HN2001000021A (es) Nuevos derivados de amidas heterociclicas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 703789

Country of ref document: ES